PLAU and hepatocellular carcinoma: To support the above mentioned results, we treated 2 more HCC cell lines (HepG2 and HA22T/VGH) with the DNA methylation inhibitor 5-aza-dC and miR-193a to verify whether uPA and MET expression may be affected.